Cross-Resistance to Medical and Agricultural Azole Drugs in Yeasts from the Oropharynx of Human Immunodeficiency Virus Patients and from Environmental Bavarian Vine Grapes-Reference-Cited by-同舟云学术

Cross-Resistance to Medical and Agricultural Azole Drugs in Yeasts from the Oropharynx of Human Immunodeficiency Virus Patients and from Environmental Bavarian Vine Grapes

Published:2007-08 Issue:8 Volume:51 Page:3014-3016
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Müller Frank-Michael C.¹²,Staudigel Andrea²,Salvenmoser Stefanie¹,Tredup Antje¹,Miltenberger Rudolf³,Herrmann Josef V.³

Affiliation:

1. Pediatric Pulmonology and Infectious Diseases, Department of Pediatrics III, University Heidelberg, Heidelberg

2. Department of Pediatrics, University Würzburg, Würzburg

3. Bavarian State Institute for Viticulture and Horticulture, Veitshöchheim, Germany

Abstract

ABSTRACT Cross-resistance among Candida albicans isolates from the oropharynges of human immunodeficiency virus-infected patients ( n = 16) and environmental yeast strains of various species ( n = 54) to medical and agricultural azole drugs was observed. Precautions against the unnecessary widespread use of azoles in the environment and human medicine are strongly recommended to prevent patients from acquiring azole-resistant yeasts.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00459-07

Reference12 articles.

1. Problematik der Entwicklung von Resistenzen humaner Mykosen gegenüber Azol-Antimykotika und eventueller Wechselwirkungen mit den als Fungizid eingesetzten Pflanzenschutzmitteln. 2001

2. Goff, D. A., S. L. Koletar, W. J. Buesching, J. Barnishan, and R. J. Fass. 1995. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin. Infect. Dis.20:77-83.

3. Gupta, A. K., and E. Tomas. 2003. New antifungal agents. Dermatol. Clin.21:565-576.

4. Ji, H., W. Zhang, Y. Zhou, M. Zhang, J. Zhu, Y. Song, and J. Lu. 2000. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. J. Med. Chem.43:2493-2505.

5. Leen, C. L., E. M. Dunbar, M. E. Ellis, and B. K. Mandal. 1990. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J. Infect.21:55-60.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hsp90 shapes adaptation by controlling the fitness consequences of regulatory variation;2023-11-02

2. Crop protection practices and risks associated with human fungal infectious diseases: a One Health perspective;Cahiers Agricultures;2023

3. Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond;PLOS Pathogens;2021-12-09

4. Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance;Mycoses;2021-12-03

5. Crossover between the control of fungal pathogens in medicine and the wider environment, and the threat of antifungal resistance;Plant Pathology;2021-07-16